Abstract

BackgroundImmune checkpoint inhibition (ICI) has been established as an essential treatment for lung and other cancers. Preclinical studies revealed that DNA-demethylating agents induced type I interferon (IFN-I) response and primed...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call